University of Pittsburgh has an available research position for Surgical Residents NIH T32 Postdoctoral Research Training in Biotherapy of Cancer to start on July 1, 2021.
This training grant is a long-standing award from the National Cancer Institute of the National Institutes of Health (NIH) to the Division of Surgical Oncology at the University of Pittsburgh to provide eligible candidates with state-of-the-art basic research training in the biological therapy of cancer. The training period is for two years.
There are four areas of focused research interests: Immunotherapy, Autophagy/DAMP biology, Oncolytic/gene therapy, and targeted molecular therapy in cancer. The goal of this program is to prepare surgeons for a career as translational scientists in the field of biologic therapy of cancer.
We will provide trainees with an immersive experience that will stress three core proficiencies necessary to be a successful translational scientist:
At the completion of this training program the surgical trainee will be uniquely prepared to bridge the gap between clinical and laboratory research.
The University of Pittsburgh is an Affirmative Action/Equal Opportunity Employer and values equality of opportunity, human dignity and diversity. EOE, including disability/vets
If you are interested in this position please email a one page description of research interest and long-term goals, current CV, and two letters of recommendation (one of which should be from your Program Director indicating your ability to participate in this program for two years) to Susan Schoonover, Research Manager, [email protected] . Selected candidates will be required to sign a two-year contract.